Through studying the potential target genes of phillyrin in treating CRC, we constructed a PPI network and, based on topological evaluation, identified eight key target genes: Bcl2, PDGFRA, MMP9, AURKB, CDK2, NR3C1, PIK3CA, and PGR. This evidence concerns the gene CDK2 and colorectal carcinoma.